MedPath

Sanofi-Aventis Deutschland Gmbh

Sanofi-Aventis Deutschland Gmbh logo
🇸🇪Sweden
Ownership
Subsidiary
Established
1863-01-01
Employees
10K
Market Cap
-
Website
http://www.sanofi-aventis.de

Clinical Trials

14

Active:10
Completed:4

Trial Phases

2 Phases

Phase 1:3
Not Applicable:4

Drug Approvals

43

NMPA:38
EMA:5

Drug Approvals

Sodium Valproate for Injection

Product Name
德巴金
Approval Number
国药准字HJ20150085
Approval Date
Jul 10, 2024
NMPA

Sodium Valproate for Injection

Product Name
德巴金
Approval Number
国药准字HJ20150084
Approval Date
Jul 10, 2024
NMPA

Insulin Glulisine Injection

Product Name
艾倍得
Approval Number
国药准字SJ20150014
Approval Date
Mar 5, 2024
NMPA

Insulin Glulisine Injection

Product Name
艾倍得
Approval Number
国药准字SJ20150013
Approval Date
Mar 5, 2024
NMPA

Insulin Glulisine Injection

Product Name
艾倍得
Approval Number
国药准字SJ20150012
Approval Date
Mar 5, 2024
NMPA

Insulin Glulisine Injection

Product Name
艾倍得
Approval Number
国药准字SJ20150008
Approval Date
Mar 5, 2024
NMPA

Insulin Glargine Injection

Product Name
来得时
Approval Number
国药准字SJ20140005
Approval Date
Jul 24, 2023
NMPA

Insulin Glargine Injection

Product Name
来得时
Approval Number
国药准字SJ20140004
Approval Date
Jul 24, 2023
NMPA

Ramipril Tablets

Product Name
瑞泰
Approval Number
国药准字HJ20140440
Approval Date
Dec 31, 2020
NMPA

Ramipril Tablets

Product Name
瑞泰
Approval Number
国药准字HJ20140441
Approval Date
Dec 31, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (57.1%)
Phase 1
3 (42.9%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.